Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived mesenchymal stem cells (Zhejiang University)
- Development stage
- Unknown
- Lead developer
- Zhejiang University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Local Injection
01
Overview
This investigational autologous cell therapy consists of mesenchymal stem cells (MSCs) derived from a patient's own adipose tissue. Developed by the Second Affiliated Hospital, School of Medicine, Zhejiang University in collaboration with Zhejiang Xingyue Biotechnology, the therapy is designed to treat chronic tendon injuries, specifically rotator cuff tears and lateral epicondylitis (tennis elbow). The treatment process involves harvesting adipose tissue, isolating and expanding the MSCs in culture, and then re-administering them via multiple point injections directly into the site of the tendon injury. These cells are intended to promote tissue regeneration, modulate the local inflammatory environment, and improve functional outcomes compared to traditional corticosteroid treatments.
- Other names
- AD-MSCsAutologous adipose-derived MSCs
Beyond the preview
Go deeper on autologous adipose-derived mesenchymal stem cells (Zhejiang University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells (Zhejiang University).